Literature DB >> 16293008

Deep brain stimulation for dystonia.

Michele Tagliati1, Jay Shils, Christina Sun, Ron Alterman.   

Abstract

Dystonia is a movement disorder characterized by involuntary muscular contractions that generate twisting and repetitive movements and/or abnormal postures. It can affect a few muscle groups (focal dystonia) or spread to most muscles in the body (generalized dystonia). While botulinum toxin injections can be successfully used to treat focal dystonias, medical options for generalized dystonia are very limited. Surgical therapies--and in particular deep brain stimulation (DBS)--are becoming the standard of care for medically intractable, disabling dystonias. Advantages of DBS include reversibility, adjustability and continued access to the therapeutic target. Initial reports describing the use of DBS in generalized dystonia have been very encouraging and experience in the use of DBS to treat various forms of dystonia is continuously growing. This article reviews the issues related to DBS treatment of dystonia, including proper patient selection, surgical approaches to target choice and device implant, a description of the stimulating device and its programming principles, clinical results - with a focus on different outcomes for primary versus secondary and generalized versus cervical dystonia - and complications.

Entities:  

Mesh:

Year:  2004        PMID: 16293008     DOI: 10.1586/17434440.1.1.33

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  10 in total

1.  Two-year outcomes of deep brain stimulation in adults with cerebral palsy.

Authors:  Ae Ryoung Kim; Jin Woo Chang; Won Seok Chang; Eun Sook Park; Sung-Rae Cho
Journal:  Ann Rehabil Med       Date:  2014-04-29

Review 2.  Mechanisms and targets of deep brain stimulation in movement disorders.

Authors:  Matthew D Johnson; Svjetlana Miocinovic; Cameron C McIntyre; Jerrold L Vitek
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

3.  Long-term effect on dystonia after pallidal deep brain stimulation (DBS) in three members of a family with a THAP1 mutation.

Authors:  P Krause; N Brüggemann; S Völzmann; A Horn; A Kupsch; G-H Schneider; K Lohmann; A Kühn
Journal:  J Neurol       Date:  2015-10-20       Impact factor: 4.849

4.  Long-term results of deep brain stimulation in a cohort of eight children with isolated dystonia.

Authors:  P Krause; K Lauritsch; A Lipp; A Horn; B Weschke; A Kupsch; K L Kiening; G-H Schneider; A A Kühn
Journal:  J Neurol       Date:  2016-08-27       Impact factor: 4.849

5.  Consultation-liaison psychiatry: how far have we come?

Authors:  Sherese Ali; Carrie Ernst; Manuel Pacheco; Gregory Fricchione
Journal:  Curr Psychiatry Rep       Date:  2006-06       Impact factor: 5.285

6.  Assessment of gliosis around moveable implants in the brain.

Authors:  Paula Stice; Jit Muthuswamy
Journal:  J Neural Eng       Date:  2009-06-25       Impact factor: 5.379

7.  Dystonia and the role of deep brain stimulation.

Authors:  Thomas L Ellis
Journal:  ISRN Surg       Date:  2011-04-13

8.  Dystonia, facial dysmorphism, intellectual disability and breast cancer associated with a chromosome 13q34 duplication and overexpression of TFDP1: case report.

Authors:  Mariana Moscovich; Mark S LeDoux; Jianfeng Xiao; Garrett L Rampon; Satya R Vemula; Ramon L Rodriguez; Kelly D Foote; Michael S Okun
Journal:  BMC Med Genet       Date:  2013-07-13       Impact factor: 2.103

9.  Deep brain stimulation suppresses pallidal low frequency activity in patients with phasic dystonic movements.

Authors:  Ewgenia Barow; Wolf-Julian Neumann; Christof Brücke; Julius Huebl; Andreas Horn; Peter Brown; Joachim K Krauss; Gerd-Helge Schneider; Andrea A Kühn
Journal:  Brain       Date:  2014-09-10       Impact factor: 13.501

10.  Low-Frequency Deep Brain Stimulation for Dystonia: Lower is Not Always Better.

Authors:  Frances M Velez-Lago; Genko Oyama; Kelly D Foote; Nelson Hwynn; Pamela Zeilman; Charles Jacobson; Samuel Wu; Michael S Okun
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-01-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.